neoplasm
• mutants exhibit myeloproliferation by 8 weeks of age and the myeloproliferation progresses to a nonfatal myeloproliferative disease-like myeloid leukemia with promyelocytic features by 6 months of age, which progresses to a myeloid leukemia with maturation in all mice older than 10 months of age
|
hematopoietic system
• mutants exhibit decreased total viable colony-forming unit, increased fraction of CFU-GM, decreased BFU-E and CFU-GEMM
|
• mutants exhibit a decrease in CFU-GEMM
|
• bone marrow is hypercellular
|
• mutants exhibit a decrease in BFU-E
|
• moderate thrombocytopenia is seen in mutants over 4 months of age
|
• all mutants over 4 months of age develop a peripheral blood myeloproliferative disorder, characterized by persistent neutrophilia, with mild leukocytosis, no anemia, and moderate thrombocytopenia, which becomes more severe with time
|
• increase in granulopoiesis in the bone marrow, with a progressive increase in promyelocytes and granulocytes
|
• persistent neutrophilia is seen in mice over 4 months of age
|
• infiltration of Gr1+, CD11b+, and CD117+ cells in the spleen
|
• the oldest leukemic mutants exhibit enlarged spleens
|
• leukemic infiltrates in the red pulp
|
immune system
• all mutants over 4 months of age develop a peripheral blood myeloproliferative disorder, characterized by persistent neutrophilia, with mild leukocytosis, no anemia, and moderate thrombocytopenia, which becomes more severe with time
|
• increase in granulopoiesis in the bone marrow, with a progressive increase in promyelocytes and granulocytes
|
• persistent neutrophilia is seen in mice over 4 months of age
|
• infiltration of Gr1+, CD11b+, and CD117+ cells in the spleen
|
• the oldest leukemic mutants exhibit enlarged spleens
|
• leukemic infiltrates in the red pulp
|
growth/size/body
• the oldest leukemic mutants exhibit enlarged spleens
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
acute promyelocytic leukemia | DOID:0060318 |
OMIM:612376 |
J:88103 |